
Trump Rails against Drug Industry, but Turns to Its Ranks to Fill Administration
Some Republicans argue industry players can use their experience to pursue reforms
STAT delivers fast, deep, and tough-minded journalism. We take you inside science labs and hospitals, biotech boardrooms, and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all.

Trump Rails against Drug Industry, but Turns to Its Ranks to Fill Administration
Some Republicans argue industry players can use their experience to pursue reforms

Trump, Breaking with Precedent, Won't Meet with U.S. Nobel Recipients
Spokesperson cites president’s foreign travel as reason; one winner says he’s “relieved”

6 Medical Innovations That Moved from The Battlefield to Mainstream Medicine
Wartime clinicians have taught us a lot about fighting infection

Tiny Human Brain Organoids Implanted in Rodents
“Micro quasi-brains” could aid disease research, but trigger ethical concerns

Scientists Solve a Dengue Mystery: Why Second Infection Is Worse Than First
Antibodies from a first bout can raise the risk of more severe disease if the virus is contracted later

Squashed in Space: Study Identifies Changes in Astronauts’ Brains
The NASA-funded work compares MRIs before and after trips

Why Heart Surgery May be Better in the Afternoon
Operations after noon have fewer bad outcomes

What the White House's Opioid Emergency Declaration Means
The move makes it easier for treatment to be prescribed remotely, but does not allocate more money for the crisis

A Start-Up Wants to Calm You Down with a Cardiac Drug You Pop Like a Mint
A company called Kick wants to market to the masses a heart medication that would be used for reversing stage fright. Some medical professionals are getting agitated

FDA Approves Second CAR-T Treatment for Cancer
The pricey therapy is designed for adults with advanced lymphoma

Will Studies of 700 Pro Fighters Help Predict Future Brain Damage?
Researchers hope blood and brain scans may detect new clues

An Anarchist Is Teaching Patients to Make Their Own Medications
The goal is to build a DIY movement to undercut high drug prices

Cancer "Moon Shot" Effort Nets New Funds with NIH–Pharma Partnership
The $215-million infusion will support immunotherapy work

Trump Administration Rescinds Obamacare Birth Control Mandate
Move lets employers cut contraceptive care from insurance benefits

Hepatitis A Outbreak Tears through San Diego Homeless Community
The disease is transmitted through contact with feces from an infected person

Experimental Drug That Mutes Defective Genes Raises New Hopes
RNA interference systems would target genetic sources and shut down protein production

U.S. States Clash Over Donated Liver Policy
The comment period for a new federal proposal ends Monday

Brain Stimulation Partly Awakens Patient after 15 Years in Vegetative State
The procedure may not work for others in a similar condition

To Advance Medicine’s Future, NIH Tries to Win the Trust of Mistreated Communities
The agency hopes to enroll 1 million people in its precision medicine effort

This Is Why Science Loves Twins
They help with tough issues like facial recognition technology and nature vs nurture

Catholic Hospitals are Multiplying, Boosting Their Impact on Reproductive Health Care
Abortions and tubal ligation numbers have dropped

Scientists Urge Caution about Study Linking Flu Vaccine to Some Miscarriages
Authors say result, based on small numbers, contradicts earlier works and prompts deeper digging

Former CDC Director Tom Frieden to Launch New Global Health Initiative
He wants to tackle trans fats and lower salt content, among other challenges

Gut Germs Appear to Play Role in Multiple Sclerosis
Are probiotics for MS next?